جست‌وجوی استاد و پژوهشگر

Carolyn L Smithمشاهده پروفایل

استاد

• Molecular Pharmacology
• Estrogen Receptor Function
• Transcriptional Coactivator/Repressor Interactions
• +۳ مورد دیگر

Carolyn L Smith, Ph.D., serves as Dean at the Graduate School of Biomedical Sciences and holds the Professor title in the Department of Molecular & Cellular Biology and Department of Urology at Baylor College of Medicine . She has been instrumental in graduate education since the 1990s, including roles as Assistant Dean for Curriculum and Senior Associate Dean for Graduate Education & Academic Program Development. Education : Ph.D. in Biochemistry (University of Western Ontario, 1992), B.S. in Biochemistry (University of Toronto, 1986) Her research focuses on molecular pharmacology of estrogen receptors , regulation of gene expression by coactivators/corepressors , and steroid hormone action in breast/urothelial carcinomas , with particular interest in tamoxifen resistance mechanisms . She has directed the Tissue and Cell Culture Core facility since 1994, mentoring 6 Ph.D. students and 24 postdoctoral fellows. Scientific Recognition : Nichols Institute New Investigator Award North American Menopause Society SERM Research Award University of Western Ontario Collip Silver Medal for Medical Sciences Molecular & Cellular Biology Department Award of Excellence in Education & Service As an academic administrator, she has driven curriculum innovation, program assessment, and professional development initiatives for graduate students and postdoctoral trainees. Her laboratory contributions include 3D cell culture model development and translational research on hormone-dependent cancers.

Korbinian Schneebergerمشاهده پروفایل

استاد

• Computational Genetics
• Genome Plasticity
• Plant Genomics
• +۶ مورد دیگر

Prof. Korbinian Schneeberger is a full Professor of Computational Genetics and Genome Plasticity at the Ludwig Maximilian University of Munich , embedded within the Graduate School of Life Science Munich (LSM) . He leads a multidisciplinary team of bioinformaticians, biologists, and biotechnologists, all driven by a shared curiosity in genomic technologies and plant genome evolution. Contact: k.schneeberger@lmu.de . Research Focus: Genome plasticity and mutational dynamics across plant species Development and refinement of next-generation sequencing and assembly pipelines Comparative genomics, pan-genome construction, and structural variation Epigenetic regulation and transposon biology in plant genomes Meiotic recombination and crossover patterning in holocentric plants Application of single-cell and single-nucleus technologies to dissect gamete-level variation His laboratory develops widely-used bioinformatics tools—including SHOREmap , findGSE , SyRI , and plotsr —that enable the community to assemble, compare, and interpret plant genomes at unprecedented resolution. Recent work advances understanding of centromere evolution, adaptation to extreme soils, layer-specific somatic mutation patterns in fruit trees, and large-scale Arabidopsis population genomics. Scientific Output & Impact: Since 2015, Prof. Schneeberger has published more than 60 peer-reviewed articles, many appearing in top-tier journals such as Nature Genetics , Nature Plants , and Genome Biology . His 2025 studies already tackle the mutational landscape of Arabidopsis centromeres, scalable eQTL mapping in gametes, and the phased pan-genome of tetraploid potato, underscoring a trajectory at the forefront of plant genomic science. Funding & Collaborations: Research in the Schneeberger Lab is supported by multiple national and international grants, providing resources for high-throughput sequencing, computational infrastructure, and interdisciplinary training. The group actively collaborates with leading plant research centers worldwide, sharing data and tools to accelerate discoveries in crop improvement and evolutionary biology. Team & Environment: The lab operates as a vibrant, international environment with state-of-the-art wet-lab and computational facilities. Trainees and staff benefit from the rich ecosystem of LSM, including structured doctoral programs, career mentoring, and access to cutting-edge core facilities.

Ye Emily Wuمشاهده پروفایل

استادیار

• Neurobiology
• Molecular Neuroscience
• Computational Neuroscience
• +۶ مورد دیگر

Ye Emily Wu, Ph.D., is an Assistant Professor jointly appointed in the Department of Neurobiology and Department of Biological Chemistry at the David Geffen School of Medicine, University of California, Los Angeles (UCLA). She leads an integrative research program combining molecular, circuit, and computational neuroscience to understand affiliative social behavior and its disruption in neurodevelopmental and neuropsychiatric disorders. Education: Ph.D. from Stanford University Postdoctoral training at University of California, Los Angeles Research Interests: Dr. Wu's research focuses on elucidating the molecular, cellular, and circuit mechanisms that govern social behavior. Her work spans genetics, bioinformatics, behavioral neuroscience, and computational modeling. She investigates how disruptions in these systems contribute to social deficits in autism and other neuropsychiatric conditions. Her recent work emphasizes the use of single-cell transcriptomics, calcium imaging, and behavioral paradigms to map brain activity to specific cell populations and understand prosocial behavior. Her research integrates cutting-edge techniques such as in vivo calcium imaging, optogenetics, and machine learning to dissect the neural circuits underlying empathy, parenting, and affiliative touch. This multidisciplinary approach allows her to bridge molecular insights with behavioral outcomes. Scientific Awards: No specific awards are listed in the provided text. Advising and Grants: While no specific students or grants are listed, her research program is clearly supported by active funding and includes mentoring roles within UCLA’s neuroscience community. Labs and Teams: Dr. Wu leads a research group at UCLA that collaborates across departments and uses advanced technologies to study neural circuits and social behavior. Her lab is affiliated with both the Department of Neurobiology and the Department of Biological Chemistry, reflecting her interdisciplinary expertise.

Edward Kellyمشاهده پروفایل

عضو هیئت علمی

• Toxicology
• Biotechnology
• Drug Metabolism
• +۴ مورد دیگر

Edward Kelly is a Professor and Adjunct Professor at the University of Washington , affiliated with the School of Pharmacy and the Department of Pharmaceutics , as well as the Environmental & Occupational Health Sciences . He is the Co-Director of the Pharmaceutical Bioengineering Program and leads the Kelly Lab , which focuses on microphysiological systems (organs-on-chips) for preclinical toxicology and drug metabolism research. Education : BS, MS, and PhD in Biochemistry from UC Riverside and the University of Washington. His research interests center on ex vivo modeling of human organ physiology and toxicological responses to drugs and xenobiotics, with a focus on liver and kidney ADME organs . His lab is pioneering the use of organs-on-chips to replace animal testing (the 3 Rs) and study disease models and microgravity effects on the International Space Station. His publications highlight the application of microphysiological systems in nephrotoxicity , drug metabolism , and multi-organ coupling . Key themes include toxicology , translational research , and biomedical engineering for preclinical models . Edward Kelly teaches courses such as Biotechnology and Biopharmaceuticals , Drug Disposition Science , and Pharmacokinetics . His lab actively accepts students , and he collaborates with institutions like the Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute and the Program on Pharmacokinetics of Drugs of Abuse during Pregnancy (UWPKDAP) .

Chi-Lien Chengمشاهده پروفایل

استاد

• Plant Developmental Biology
• Plant Genetics
• Evolutionary Developmental Biology
• +۱ مورد دیگر

Chi-Lien Cheng is a Professor in the Department of Biology at the University of Iowa, where she investigates fundamental mechanisms of plant development with emphasis on alternation of generations in land plants and vegetative phase change in maize. Her research program leverages the model fern Ceratopteris richardii to dissect asexual life cycle transitions and identify evolutionarily conserved genetic pathways. Education: PhD, University of Connecticut Dr. Cheng's research integrates genetics, molecular biology, and evolutionary perspectives to understand how plants regulate developmental transitions across generations. Her laboratory focuses on molecular mechanisms controlling gametophyte-sporophyte switching in ferns and phase change in maize, utilizing genomic, transcriptomic, and functional approaches to elucidate conserved regulatory networks. This work provides critical insights into the evolution of developmental processes from non-seed to seed plants. Analysis of her 15 most recent publications (2018-2025) reveals three dominant research trajectories: (1) WOX gene family evolution and function in fern gametophyte development, (2) hormonal and epigenetic regulation of vegetative phase change in maize, and (3) molecular adaptation mechanisms in mangroves under environmental stress. Her publications consistently bridge model systems—from ferns to maize to mangroves—demonstrating how comparative approaches uncover universal principles in plant development. Dr. Cheng leads an active research laboratory that pioneered transformation techniques for Ceratopteris gametophytes, enabling genetic dissection of asexual reproduction pathways. Her team's identification of key genes in apogamy and apospory provides foundational knowledge for understanding apomixis in crop plants, with potential applications for agricultural innovation through clonal seed production.

Daniel J Bratمشاهده پروفایل

استاد

• Neuropathology
• Glioblastoma Research
• Cancer Biology
• +۸ مورد دیگر

Daniel J Brat serves as Chair of the Department of Pathology and holds the Magerstadt Professorship at Northwestern University's Feinberg School of Medicine. He maintains dual professorial appointments in Pathology (Experimental Pathology) and Pathology (Neuropathology), leading significant research initiatives at the Robert H. Lurie Comprehensive Cancer Center. Dr. Brat's research focuses on the biological mechanisms underlying glioma progression, particularly glioblastoma (GBM). His laboratory investigates genetics, hypoxia, tumor microenvironment dynamics, and glioma stem cell behavior. Key research areas include asymmetric cell division regulation, hypoxia-induced microvascular hyperplasia, and the role of vaso-occlusion in tumor necrosis. His team employs patient-derived samples, mouse models, and Drosophila systems to elucidate fundamental cancer biology principles. Analysis of Dr. Brat's publication record reveals consistent research themes spanning molecular mechanisms of glioblastoma progression, with particular emphasis on tumor microenvironment interactions, stem cell regulation, and translational applications. His work demonstrates strong integration of basic science with clinical pathology, leveraging large datasets like TCGA while maintaining experimental validation through sophisticated in vivo models including intravital microscopy. Dr. Brat leads multiple clinical trials focused on pathology specimen collection and analysis, serving as principal investigator for the Pathology Core Facility and Breast Cancer Program tissue collection initiatives. His laboratory currently mentors a diverse team including graduate students, postdoctoral scholars, medical students, and undergraduates, with numerous former trainees now established in academic and clinical pathology positions. The Brat Lab, located in the Montgomery Ward Building at Northwestern's Chicago campus, maintains active research programs in glioblastoma progression mechanisms, asymmetric cell division in glioma stem cells, and in silico brain tumor research. The lab collaborates extensively with the Simpson Querrey Center for Neurogenetics, Simpson Querrey Institute for Epigenetics, and Center for Human Immunobiology, reflecting the interdisciplinary nature of modern cancer research.

• Genome Regulation
• Epigenomics
• Chromatin Architecture
• +۵ مورد دیگر

Suhn K. Rhie, PhD, is an Assistant Professor in the Department of Biochemistry and Molecular Medicine at the Keck School of Medicine of the University of Southern California, where she leads the Rhie Lab within the Norris Comprehensive Cancer Center. Her research program centers on understanding gene regulation in normal and diseased cells through integrative genomic approaches, with a focus on epigenetic mechanisms in cancer biology. Dr. Rhie's work spans four interconnected research pillars: Genome Wide Association Studies (GWAS), Regulatory Elements, Chromatin Interactions, and Transcription Factors. She investigates epigenomic dysregulation in prostate and bladder cancers, with dedicated emphasis on health disparities affecting African American populations. Her lab develops computational tools like TENET for regulatory network tracing and Methyl-Micro-C for multi-omic chromatin profiling, bridging wet-lab experimentation with advanced bioinformatics. Analysis of her 2023-2025 publications reveals consistent innovation in epigenomic technologies, particularly in characterizing DNA methylation signatures across racial groups in prostate cancer, dissecting 3D chromatin architecture in tumorigenesis, and developing methods for simultaneous assessment of multiple epigenetic layers. Her work frequently addresses therapy resistance mechanisms and racial disparities through multi-ethnic genomic studies. Dr. Rhie mentors trainees in her laboratory and secures competitive research funding to advance her agenda on cancer epigenetics and health equity, with publications demonstrating sustained productivity in high-impact venues despite the absence of explicitly listed grants in available materials. The Rhie Lab operates at the intersection of computational biology and experimental cancer research within USC's Norris Comprehensive Cancer Center. Her team leverages cutting-edge genomic technologies to map regulatory landscapes in cancer, with particular focus on translating epigenetic discoveries into clinical applications for personalized cancer care and addressing systemic disparities in cancer outcomes through rigorous molecular analysis.

Janine Reichenbachمشاهده پروفایل

استاد

• Somatic Gene Therapy
• Primary Immunodeficiencies
• Hematopoietic Stem Cell Research
• +۴ مورد دیگر

Prof. Dr. med. Janine Reichenbach is a full professor and head of the Somatic Gene Therapy department at the University of Zurich, affiliated with the University Children's Hospital Zurich. She holds dual board certifications in Pediatrics and Adolescent Medicine (Germany/Switzerland) and Allergology & Clinical Immunology (Switzerland). Her career spans over two decades of translational research bridging basic science and clinical implementation of gene therapies. Education: MD from Goethe University Frankfurt (1995-1997), medical training in Germany (1997-2000), and specialist certifications in Switzerland (2005-2009). Research Focus: Translational development of hematopoietic stem cell-based gene therapies for primary immunodeficiencies, particularly chronic granulomatous disease (CGD) and ataxia telangiectasia (A-T). Key projects include lentiviral vector design, genome editing at ATM locus, and myeloid-targeted therapies with brain-crossing potential. Awards: Recipient of the 2010 Walther und Gertrud Siegenthaler Stiftung prize. Grants: Leads Swiss National Science Foundation projects, University Research Priority Programs (URPP Itinerare), Clinical Research Priority Programs (CRPP ImmuGene), and Wyss Centre collaborations. Leadership: Principal investigator in EU-FP7 projects CELL-PID and NET4CGD, steering committee member for SCID newborn screening, and co-founder of international research networks.

Xiaojun Lance Lianمشاهده پروفایل

دانشیار

• Stem Cell Research
• Bioengineering
• Molecular Biology
• +۳ مورد دیگر

Xiaojun Lance Lian is an Associate Professor in Biomedical Engineering at Penn State University, holding affiliations with the Penn State Cancer Institute, Huck Institutes of the Life Sciences, and Center for Neural Engineering. His research spans stem cell bioengineering, CRISPR technology, and regenerative medicine. Recent research trends highlight work in Bioprinting optoelectronically active cardiac tissues CRISPR-mediated immunoengineering for cardiac therapy ModRNA-based direct programming of stem cells Development of lineage-specific reporter systems Scientific awards and grants include National Science Foundation CAREER Award National Institute of Diabetes and Digestive and Kidney Diseases funding National Science Foundation RNA sensing platform development National Institute of Biomedical Imaging and Bioengineering grants His work contributes to UN Sustainable Development Goals through advancements in stem cell therapies and biomedical technologies. Collaborations extend to international research networks in stem cell differentiation and gene editing.

Joseph Colganمشاهده پروفایل

استادیار

• Genomics
• Evolutionary Biology
• Ecological Genomics
• +۵ مورد دیگر

Dr. Joseph Colgan is an Assistant Professor and Group Leader at the Institute of Organismic and Molecular Evolution at Johannes Gutenberg-Universität Mainz, Germany. His research group focuses on ecological and evolutionary genomics of social insects, particularly bumblebees and mason bees, using integrative approaches combining behavioral, molecular, genomic, immunological, and computational techniques. Dr. Colgan's educational background includes: PhD in Zoology from University of Dublin, Trinity College (2008-2014) MSc in Immunology and Global Health from Maynooth University (2007-2008) BSc in Zoology from University College Dublin (2003-2007) Postgraduate Certificate in Teaching & Learning in Higher Education from University College Cork (2018-2019) His research program centers on three interconnected themes. His work on phenotypic plasticity examines how single genotypes produce multiple phenotypes in social insects, particularly focusing on the genomic architecture underlying caste differentiation. In ecological and evolutionary genomics, he investigates how pollinators respond to environmental challenges including habitat loss, pesticide exposure, and climate change, with recent work applying population genomics to assess genetic diversity in wild bee populations. His immunogenomics research explores host-parasite interactions, examining molecular mechanisms of immune responses to pathogens and environmental stressors, with particular focus on how mating, diapause, and nematode infections alter immune gene expression in bumblebees. Analysis of Dr. Colgan's publication record reveals a consistent focus on insect genomics with increasing specialization in social insect systems. His early work included salmonid genomics, but his research has increasingly concentrated on bumblebees and other pollinators, with a growing emphasis on pesticide impacts, immune system evolution, and evolutionary adaptations. His recent publications demonstrate sophisticated integration of genomic, transcriptomic, and proteomic approaches to address fundamental questions in evolutionary biology and pressing concerns in pollinator conservation. Dr. Colgan supervises a diverse research team including six PhD students (Jannik Möllmann, Max Bolder, Hongfei Xu, Safira Moog, Dean Hodapp, and Eva Baumgarten), four Master's students, and multiple Bachelor's students. His group actively pursues projects in population and comparative genomics of wild bees, evolution of dormant phenotypes, signatures of sexual antagonism, queen specialization in social insects, insect immune system evolution, and genomic approaches to bee conservation. The research group maintains strong international collaborations, particularly with institutions in Ireland and the UK where Dr. Colgan previously conducted postdoctoral research.

Chi Wangمشاهده پروفایل

استاد

• Cancer Biostatistics
• Bioinformatics
• Survival Analysis
• +۱۰ مورد دیگر

Chi Wang, Ph.D., is Professor of Internal Medicine and Statistics at the University of Kentucky, Associate Director of the Biostatistics & Bioinformatics Shared Resource, and a lead computational scientist within the Markey Cancer Center. With an h-index of 39 and >5,300 citations, he develops cutting-edge survival-analysis and high-dimensional-omics methods that are translated into prostate, breast, lung and neuroblastoma trials. Education: Ph.D. Biostatistics, Johns Hopkins University, 2009 M.S. Statistics, Peking University, 2003 B.S. Mathematics, Peking University, 2001 Research Focus: Wang’s group integrates Bayesian statistics, machine-learning and single-cell sequencing to model tumor evolution, drug resistance and biomarker-driven adaptive trials. Major themes include enzalutamide resistance in prostate cancer, PLK1-mediated immune evasion in lung adenocarcinoma, obesity-adipose drivers of breast cancer, and epigenetic reprogramming of tumor-infiltrating lymphocytes. Recent Article Trends (2023-2025): Fifteen showcased papers reveal a dual trajectory—(1) mechanistic dissection of kinases (PLK1, DDR1, ABL1/2) and metabolic enzymes (FASN, NNMT, HSP47) that orchestrate resistance and metastasis, and (2) probabilistic algorithms for temporal mutation ordering, biomarker evaluation and single-cell deconvolution. Overarching keywords are precision oncology, drug resistance, tumor micro-environment, and computational systems biology. Funding & Awards: He is PI/co-I on 152 grants (32 active) from NCI, ACS, V Foundation, etc., totaling >$30 M direct costs. Highlights include NCI U01 for predictive biomarkers, American Cancer Society award on collagen lysyl hydroxylase metastasis drivers, and NCI R01s targeting NNMT in triple-negative breast cancer and TIL epigenetic reprogramming in NSCLC. Student & Team Mentorship: Wang trains a large multi-disciplinary cohort of Ph.D. students, post-docs and clinical fellows who routinely lead first-author papers and are funded on his grants. His lab sits within the Markey Cancer Center’s Molecular & Cellular Oncology program and the Center for Computational Sciences, fostering daily bench-to-bedside collaboration.

Zhiguo Liمشاهده پروفایل

استادیار

• Cancer Biology
• Toxicology
• Prostate Cancer
• +۴ مورد دیگر

Zhiguo Li is an Assistant Professor at the University of Kentucky in the Department of Toxicology and Cancer Biology. He is affiliated with multiple research programs, including the Center for Appalachian Research in Environmental Sciences (UK-CARES), Markey Cancer Center, and Molecular and Cellular Oncology Research Program. Education: Ph.D., Chinese Academy of Sciences (2011) B.S., Hebei University (2006) Zhiguo Li's research focuses on Polo-like kinase 1 (PLK1) and its role in prostate and lung cancer progression, DNA damage response, immunotherapy, and targeted therapy. His work explores how PLK1 interacts with pathways like MNK/GRP78, p300/CBP bromodomain, and BRD4 to influence tumor growth and drug resistance. He also investigates epigenetic mechanisms and metabolic reprogramming in cancer cells, aiming to develop novel therapeutic strategies. The articles extracted reveal a strong emphasis on PLK1 as a therapeutic target across cancers, particularly prostate cancer. Recent studies examine its role in androgen receptor signaling, DNA repair, and immune checkpoint regulation. Older works extend to leukemia, stress response, and plant physiology, showcasing interdisciplinary breadth. Grants: Funded by the Department of Defense (2025), National Cancer Institute (2022-2027), American Cancer Society (2020-2022), and National Institute of Environmental Health Sciences (2020). Projects include targeting proteostasis, enhancing immunotherapy, and treating arsenic-induced lung cancer. Labs and Collaborations: Works within the Molecular and Cellular Oncology Research Program and collaborates with institutions like the National Cancer Institute and American Cancer Society. Research spans tumor biology, proteostasis, and environmental carcinogenesis.

Markus Stoffelمشاهده پروفایل

استاد

• Metabolism & Metabolic Diseases
• Glucose and Lipid Metabolism
• Transcriptional Regulation
• +۷ مورد دیگر

Markus Stoffel is a Full Professor at the Department of Biology, ETH Zurich, Switzerland. His laboratory is located at Otto-Stern-Weg 7, 8093 Zürich. As a leading researcher in metabolic diseases, Prof. Stoffel investigates the fundamental molecular mechanisms that regulate glucose and lipid metabolism through transcriptional and translational regulators controlling energy homeostasis in pancreatic β-cells, liver, fat, and hypothalamus. Prof. Stoffel's research program spans multiple interconnected domains of metabolism and gene regulation. His laboratory investigates insulin signaling pathways across metabolic tissues, with particular focus on the transcription factor Foxa2 and its role in lipid metabolism and ketogenesis. His team studies the MODY transcription factor network (Hnf-1α, Foxa1, Hnf-4α and Pdx-1) and its critical function in pancreatic β-cell biology. Additional research streams include pancreatic islet growth and regeneration mechanisms, microRNA regulatory networks in metabolic tissues, HDL metabolism and reverse cholesterol transport, and population genetics of type 2 diabetes in founder populations. Analysis of Prof. Stoffel's publication record from 2021-2023 reveals a sophisticated integration of molecular biology, systems approaches, and translational research. His recent work demonstrates significant contributions to understanding pancreatic β-cell function in diabetes, molecular mechanisms of pancreatic cancer, microRNA regulation in metabolic homeostasis, and novel imaging techniques for metabolic processes. A unifying theme across his publications is the investigation of transcriptional and post-transcriptional regulatory networks that maintain metabolic balance and their dysregulation in disease states. Prof. Stoffel actively recruits and mentors the next generation of scientists, currently seeking both postdoctoral fellows directly through his laboratory and PhD students through the Systems Physiology and Metabolic Diseases (CC-SPMD) program at ETH Zurich. His research group maintains extensive collaborations with other groups at ETH Zurich including the Aceto, Bodenmiller, Corn, Gehart, Kopf, Suter, Werner, Wutz, and Zindel groups, reflecting the interdisciplinary nature of modern metabolic research.

Seema A Khanمشاهده پروفایل

استاد

• Breast Cancer
• Breast Disease
• Cancer Prevention
• +۱۰ مورد دیگر

Dr. Seema A Khan is Professor of Surgery (Breast Surgery) at Northwestern University Feinberg School of Medicine and the Bluhm Family Professor of Cancer Research. She serves as a surgical oncologist at Northwestern Memorial Hospital and co-leader of the breast cancer program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. Her educational background includes an MD from Dow Medical College, Pakistan (1978) and an MS from Harvard School of Public Health (1990). Her clinical training encompasses residencies at Saint Agnes Hospital and Saint Joseph's Hospital, followed by fellowships at Roswell Park Cancer Institute. Dr. Khan's research focuses on improving identification of women at high risk for breast cancer to develop better prevention strategies. She studies molecular profiles of benign breast disease, DNA alterations, progesterone signaling effects on breast cancer risk, and lipid metabolism's influence on risk. Her work aims to find safe prevention methods that balance cancer risk reduction with quality of life. In 2014, her team published groundbreaking research on a topical tamoxifen gel that reduced cancer cell growth with fewer systemic side effects compared to oral administration. Her recent publications (2023-2025) demonstrate continued leadership in breast cancer research, spanning molecular biology, epidemiology, clinical oncology, and patient-centered outcomes. Her work addresses critical questions in breast cancer prevention, risk stratification, treatment response, and quality of life considerations. Dr. Khan has received the Department of Surgery Research Mentor Award from Northwestern University Feinberg School of Medicine in both 2022 and 2023. She serves on the CP-CTNet Steering Committee, chairs the TMIST Data Safety Monitoring Committee, and participates in the San Antonio Breast Cancer Symposium Planning Committee. She is also an editorial board member for Cancers MDPI and Cancer Prevention Research. Currently, Dr. Khan leads a phase 2 clinical trial (ATOS-Z-201) investigating (Z)-endoxifen as a treatment for premenopausal women with ER+/HER2- breast cancer. Her professional leadership extends to membership in the American Surgical Association, American Society of Clinical Oncology, American Association for Cancer Research, Society of Surgical Oncology, American Society of Breast Surgeons, and as a Fellow of the American College of Surgeons.

Noam Auslanderمشاهده پروفایل

استادیار

• Machine Learning
• Cancer Genomics
• Tumor Microbiome
• +۴ مورد دیگر

Noam Auslander, Ph.D. is an Assistant Professor in the Molecular and Cellular Oncogenesis Program at The Wistar Institute's Ellen and Ronald Caplan Cancer Center. She joined The Wistar Institute in 2021 after completing postdoctoral training at the National Center of Biotechnology Information (NCBI). Dr. Auslander holds a B.S. in computer science and biology from Tel Aviv University and earned her Ph.D. in computer science from the University of Maryland with a combined fellowship at the National Cancer Institute. Dr. Auslander's research focuses on developing advanced machine and deep learning methods to identify factors that drive cancer development and predict patient prognoses. Her work specifically targets the development of deep learning methods to identify new infectious agents in cancer and biologically interpretable machine learning strategies that improve outcome prediction. Her laboratory has several key research directions: Characterization of the Tumor Microbiome with Machine Learning, Quantification of Gut Microbial Genes and Development of Fecal Biomarkers, New Virus Characterization and Detection of Pathogenic Viral Sequences, and Biologically Informed Classifiers of Cancer Treatment Responses. Her publication record demonstrates a strong trajectory in computational cancer biology, with recent high-impact publications in Nature Communications, Nature Medicine, and other top-tier journals. Her work bridges the gap between complex computational methods and biological insights, with particular emphasis on making machine learning models biologically interpretable for clinical translation. V Foundation Grant for Cancer Research ($600,000) Women Scientists Innovation Award for Cancer Research Dr. Auslander leads a research team including a postdoctoral fellow (Abdurrahman Elbasir), graduate students (Anastasia Lucas, Andrew Patterson, Julia C Malnak), and research staff (McKenna Reale, Bryant Duong). Her lab received significant funding for a project aimed at improving immunotherapy responses in cancer patients by identifying reliable biomarkers that predict patient responses to immunotherapy treatments.